PF-07202954
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07202954, covering 2024-09-20 to 2024-09-20. Get the full timeline:
Most recent: Clinical Trial Update: Study in Healthy Adults Evaluating PF-07202954 [Phase 1]